AI assistant
Zoetis Inc. — Director's Dealing 2019
Apr 2, 2019
29945_dirs_2019-04-02_d2a909c8-7871-4ca4-8d88-c71d7dc30ef4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Zoetis Inc. (ZTS)
CIK: 0001555280
Period of Report: 2019-04-01
Reporting Person: Lagano Roxanne (Executive Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-04-01 | Common Stock | M | 2000 | $30.89 | Acquired | 30727 | Direct |
| 2019-04-01 | Common Stock | S | 2000 | $101.89 | Disposed | 28727 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-04-01 | Stock Option | $ | M | 2000 | Disposed | Common Stock (2000.0) | Direct |
Footnotes
F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 14, 2018.
F2: The Price reported in Table I, Column 4 is the price at which these shares were sold in multiple transactions.
F3: Stock options (right to buy Zoetis Inc. common stock) granted pursuant to the Zoetis Inc. 2013 Equity and Incentive Plan. The options vest on the third anniversary of the date of grant.
F4: 2,000 options granted March 4, 2014 at an exercise price of $30.89 per option.
F5: Each option vests on the third anniversary of the date of grant.
F6: Each option expires on the tenth anniversary of the date of grant.
F7: 29,453 options granted March 4, 2014 at an exercise price of $30.89 per option; 17,852 options granted February 27, 2015 at an exercise price of $46.09 per option; 19,362 options granted February 19, 2016 at an exercise price of $41.83 per option; 17,482 options granted February 14, 2017 at an exercise price of $55.02 per option; 13,964 options granted February 13, 2018 at an exercise price of $73.24 per option; and 12,052 options granted February 12, 2019 at an exercise price of $87.51.